SCHEMBL6537524

SCHEMBL6537524

Cc1ccc(NC=C(C(=O)O)C(=O)O)c([N+](=O)[O-])c1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
MAPT P10636 3/20 0.56
LMNA P02545 2/20 0.53
NPC1 O15118 6/20 0.51
RAB9A P51151 5/20 0.51
KCNMA1 Q12791 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
KAT2B Q92831 2/20 0.47
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
HTT P42858 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8472886 1.00 ALDH1A1 (0.58) ALDH1A1MAPTLMNANPC1RAB9A
SCHEMBL6538195 0.89 MAPT (0.70) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL6538193 0.89 MAPT (0.70) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL6536820 0.83 KCNMA1 (0.49) ALDH1A1MAPTLMNAKCNMA1MAPK1
SCHEMBL6536822 0.83 KCNMA1 (0.49) ALDH1A1MAPTLMNAKCNMA1MAPK1
SCHEMBL6537866 0.83 APP (0.54) ALDH1A1MAPTLMNANPC1RAB9A
SCHEMBL6537862 0.83 APP (0.54) ALDH1A1MAPTLMNANPC1RAB9A
SCHEMBL8473074 0.82 MAPT (0.49) ALDH1A1MAPTLMNANPC1RAB9A
SCHEMBL6537753 0.82 MAPT (0.49) ALDH1A1MAPTLMNANPC1RAB9A
SCHEMBL6538200 0.81 MAPT (0.57) ALDH1A1MAPTLMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed